Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs
Abstract Gold compounds are a promising class of experimental anticancer metallodrugs. Unlike platinum-based drugs, their antiproliferative effects are thought to result mainly from modulation of cancer cell metabolism rather than direct interaction with DNA. Previous NMR studies have shown that fou...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Systems Biology and Applications |
| Online Access: | https://doi.org/10.1038/s41540-025-00535-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849332398234271744 |
|---|---|
| author | Walter Vieri Veronica Ghini Paola Turano Lara Massai Luigi Messori Marco Fondi |
| author_facet | Walter Vieri Veronica Ghini Paola Turano Lara Massai Luigi Messori Marco Fondi |
| author_sort | Walter Vieri |
| collection | DOAJ |
| description | Abstract Gold compounds are a promising class of experimental anticancer metallodrugs. Unlike platinum-based drugs, their antiproliferative effects are thought to result mainly from modulation of cancer cell metabolism rather than direct interaction with DNA. Previous NMR studies have shown that four cytotoxic gold compounds - auranofin, aurothiomalate and two gold N-heterocyclic carbenes - induce distinct metabolic changes in A2780 ovarian cancer cells, suggesting the occurrence of different mechanisms of action. To better understand these effects, we constructed a genome-scale metabolic model (GEM) of A2780 cells to analyze the NMR-detected metabolomic changes. The model successfully predicts the diverse metabolic responses induced by each gold compound and identifies common metabolic changes. These results confirm the potential of GEMs as a powerful tool for interpreting and predicting cellular responses to gold-based drugs, providing insights into their mechanisms of action and potential therapeutic applications. |
| format | Article |
| id | doaj-art-aebf5a68274a47d089c97bfdc4694d69 |
| institution | Kabale University |
| issn | 2056-7189 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | npj Systems Biology and Applications |
| spelling | doaj-art-aebf5a68274a47d089c97bfdc4694d692025-08-20T03:46:12ZengNature Portfolionpj Systems Biology and Applications2056-71892025-07-011111910.1038/s41540-025-00535-9Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugsWalter Vieri0Veronica Ghini1Paola Turano2Lara Massai3Luigi Messori4Marco Fondi5Department of Biology, University of FlorenceDepartment of Chemistry, University of FlorenceDepartment of Chemistry, University of FlorenceDepartment of Chemistry, University of FlorenceDepartment of Chemistry, University of FlorenceDepartment of Biology, University of FlorenceAbstract Gold compounds are a promising class of experimental anticancer metallodrugs. Unlike platinum-based drugs, their antiproliferative effects are thought to result mainly from modulation of cancer cell metabolism rather than direct interaction with DNA. Previous NMR studies have shown that four cytotoxic gold compounds - auranofin, aurothiomalate and two gold N-heterocyclic carbenes - induce distinct metabolic changes in A2780 ovarian cancer cells, suggesting the occurrence of different mechanisms of action. To better understand these effects, we constructed a genome-scale metabolic model (GEM) of A2780 cells to analyze the NMR-detected metabolomic changes. The model successfully predicts the diverse metabolic responses induced by each gold compound and identifies common metabolic changes. These results confirm the potential of GEMs as a powerful tool for interpreting and predicting cellular responses to gold-based drugs, providing insights into their mechanisms of action and potential therapeutic applications.https://doi.org/10.1038/s41540-025-00535-9 |
| spellingShingle | Walter Vieri Veronica Ghini Paola Turano Lara Massai Luigi Messori Marco Fondi Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs npj Systems Biology and Applications |
| title | Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs |
| title_full | Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs |
| title_fullStr | Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs |
| title_full_unstemmed | Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs |
| title_short | Modeling the metabolic response of A2780 ovarian cancer cells to gold-based cytotoxic drugs |
| title_sort | modeling the metabolic response of a2780 ovarian cancer cells to gold based cytotoxic drugs |
| url | https://doi.org/10.1038/s41540-025-00535-9 |
| work_keys_str_mv | AT waltervieri modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs AT veronicaghini modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs AT paolaturano modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs AT laramassai modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs AT luigimessori modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs AT marcofondi modelingthemetabolicresponseofa2780ovariancancercellstogoldbasedcytotoxicdrugs |